["I have swollen lymph nodes"].
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to F Waldvogel.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
We performed an observational cohort study to test the ability of a short-form screening procedure to detect unrecognized functional disability, as well as its capacity to predict clinical outcome. This screening procedure was administered to 198 consecutive patients within 48 hours of admission. Clinical outcomes upon discharge from the acute care hospital and at 3 months were analyzed according to the number of functional disabilities present on admission. This brief test identified a mean of 1.8 and a median of 1 previously unrecognized functional disabilities per patient. The presence of two or more functional disabilities on admission (48% of the study population) was significantly associated with a negative outcome upon discharge (relative risk = 1.73; CI, 1.33-2.25; p = 0.0001) and at 3 months after discharge (relative risk = 1.34; CI, 1.10-1.64; p = 0.003) confirming the reliability of the short-form screening procedure.
The Wiskott-Aldrich syndrome is an X-linked inherited immunodeficiency disorder characterized by thrombocytopenia, recurrent infections and eczema. Its best management option is HLA-identical bone marrow transplantation; when this is not feasible, splenectomy, followed by continuous prophylactic antibiotics, represents the alternative of choice. The present case report relates the excellent outcome of an adult with the Wiskott-Aldrich syndrome who suffered his first major complication of the disease at age 33 years, an intracerebral hemorrhage. Since an uneventfull splenectomy, thrombocytopenia has significantly improved, and he has remained free of infections for a follow-up period of 3 years while being treated with prophylactic antibiotics.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Plasma measurement of D-Dimer (DD) represents a definite aid in the diagnostic approach of outpatients with suspected venous thromboembolism (VTE). However, the high sensitivity (about 95%) of the test which allows to rule out VTE when concentrations are below a given cutoff (500 micrograms/L as measured by the ELISA technique) is counterbalanced by a poor specificity (about 40%). Because the specificity might even be lower in patients who are hospitalized we determined the DD plasma concentration in 255 patients who were consecutively admitted in general internal medicine wards with various pathological conditions. The proportion of patients who had DD levels below the cutoff of 500 micrograms/L was 6% (1/18) in patients with VTE and 22% (52/237) in hospitalized patients without VTE: the figure was 21% in patients with pulmonary infections, 14% in patients with other infections, 11% in patients with neoplastic diseases, 34% in patients with coronary or cerebrovascular disease, 19% in patients with cardiac failure, 69% in patients with rheumatologic disease and in 16% in subjects with miscellaneous clinical conditions. The high rate of elevated plasma DD in hospitalized patients questions the usefulness of this test in the diagnostic approach of VTE in aged patients who present with concomitant disease like infections, neoplasia, cardiac failure and many other pathological conditions, except rheumatologic affections and coronary or cerebrovascular diseases.
Explore the source record for details and available documents.
Internal medicine has recently undergone major changes, which have created--among others--4 feelings of alienation among physicians: first, the internist--initially an observer of clinical signs, and later laboratory-assisted--has now become operator-assisted with modern technology in imaging and other technologies assisting him by giving him not the essence, but the interpretation of the gathered information; second, the dialogue between basic biomedical research and the bedside clinician has been interrupted by the creation of a new language in molecular genetics, to which he has no access any more; third, modern biotechnology is rapidly creating an unlimited number of new biological therapeutic modalities, giving the internist too many therapeutic options which he can no longer master. Fourth, the formerly direct, bipolar relationship between patient and physician has been extended to a triangular relationship between patient, physician and an institution (hospital administration, public health authority, health insurance). In order to solve these problems, internal medicine has several options. First, maintaining the dialogue in research across subspecialties by creating a group of full time clinical investigators, with training in basic molecular and cellular biology, who can be the interface between modern molecular genetics and clinical internal medicine; and second, developing new clinical investigators to evaluate our diagnostic and therapeutic strategies with a logical and scientific methodology: patient care analysis, health care research, medical outcome evaluation and quality assessment are all disciplines which will link the various fields of internal medicine into a tight network. To do this, the Swiss Society of Internal Medicine has to modify its structures, to become a scientific and a professional organization, cognizant of the evolution of medicine within the European scene.
We have identified an eating disorder in 13% of women hospitalized on a medical ward for various reasons. These as well as obese patients undergo wide fluctuations of weight sometimes exceeding 30% of their present weight. Surprisingly, even in the absence of eating disorders, the changes in weight during adulthood are marked (22% of present body weight). Weight history should be included systematically in the medical history, since it can underscore concern over weight or even an unrecognized eating disorder.
We review the 257 patients hospitalized for meningitis in the Cantonal University Hospital, Geneva between 1st January 1980 and 31st December 1986. 104 patients had acute bacterial meningitis (32 Str. pneumoniae, 21 N. meningitidis, 10 Listeria monocytogenes, 8 streptococci, 5 H. influenzae, 5 staphylococci, 4 gram negative bacilli and 19 without identified bacteria), 124 patients had viral meningitis and 29 meningitis of other etiologies (6 tuberculous meningitis, 2 fungal meningitis, 1 leptospiral meningitis, 5 neoplastic meningitis--one already counted because of a meningitis due to Staph. epidermidis--2 meningitis consecutive to a meningeal irritation, 4 already treated meningitis of undetermined etiology, 2 chronic meningitis and 8 meningoencephalitis). The total mortality was 14.4%. It was zero in viral meningitis and 28% in bacterial meningitis (47% in cases of Str. pneumoniae, 5% in cases of N. meningitidis, 20% in cases of Listeria monocytogenes, 38% in cases of streptococci, 0% in cases of H. influenzae, 60% in cases of staphylococci, 50% in cases of gram negative bacilli, 16% in cases of unidentified bacteria). The striking difference in mortality emphasizes the importance of recognizing a bacterial etiology in order to institute antibiotic therapy as soon as possible. The delay between admission and lumbar puncture averaged 15 hours (range 0.25-96 h) in patients with acute bacterial meningitis and 6.3 hours (0.5-80 h) in patients with viral meningitis. The delay between admission and institution of the antibiotics averaged 5.3 hours (1-48 h) in cases of acute bacterial meningitis and 4.8 hours (0.5-48 h) in cases of viral meningitis. A better clinical workup may provide a reliable diagnosis sooner. In the collective with bacterial and viral meningitis headaches, fever or nuchal rigidity were present in over 80% of the cases. The following features were significantly associated with a bacterial etiology: age over 30 years, alcoholism, concomitant neoplasm, cough, coma, pulmonary rales, new neurological signs or petechia. At least one of these 4 latter signs was present in more than 70% of the cases with acute bacterial meningitis compared to 6% in cases of viral meningitis. Thus the clinical presentation alone serves to recognize the meningitis and to differentiate between a bacterial or viral etiology, thus permitting an immediate therapeutic decision without waiting for complementary investigations. The 104 patients with acute bacterial meningitis were treated with antibiotics: 60 with penicillin, 17 with ampicillin and 26 with other antibiotics; one case did not receive antibiotics. More than the half of the cases with viral meningitis have got antibiotics (52%).
Explore the source record for details and available documents.
Midazolam is a short-acting benzodiazepine with a short half life (1.5-2.5 h) due to intense biotransformation by liver monooxygenases. Anecdotal clinical reports have mentioned a wide interpatient variability in its duration of action. We investigated by in vitro screening factors that could interfere with the rate of midazolam biotransformation (drug-drug interactions). Metabolite production (1'-and 4-OH-midazolam) was monitored in human liver microsomes. Midazolam hydroxylations are inhibited by several drugs (i.e. erythromycin, phenothiazine-type neuroleptics, cyclosporine). The clinical relevance of these drug interactions is illustrated by the example of a patient treated with amiodarone, erythromycin and midazolam during anesthesia. Midazolam-induced sleep lasted about 6 days due to inhibition of its biotransformation by concomitant drug treatment.
Between 1983 and 1987, 19 patients presenting with encephalic involvement of AIDS had an EEG recording during the early neurological examination. In 8 patients, EEGs were repeated 1 to 11 times during the course of the disease. All recordings were abnormal. A good EEG correlation existed with clinical, virological and bacteriological (SF), radiological, and histological data (10 cases). EEG recordings are useful to study the encephalic pathology of AIDS, not only for its secondary, but even more for its primary involvement.
In this clinical-pathological conference the case of a patient with aplastic anemia is presented who recovered after treatment with prednisone and antilymphocyte serum. The patient's clinical course was however complicated by persistent fever and panuveitis. This was followed by acute mitral insufficiency and left ventricular failure, leading to the patient's death.
Explore the source record for details and available documents.
In a prospective, randomized trial, teicoplanin (at a 400-mg intravenous loading dose followed by 200 mg/day intravenously or intramuscularly) was compared with flucloxacillin (8 g/day) in patients with severe staphylococcal infections. Teicoplanin proved unsatisfactory for the following reasons: failures or relapses were more frequent in the teicoplanin group, and blood levels were difficult to predict and tended to be low 24 hr after the loading dose. Future trials with this agent should use much-higher doses.
Using a previously developed guinea pig model of foreign body infection, we examined ultrastructural and functional surface alterations of Staphylococcus aureus strain Wood 46 during the early phase of infection. Exopolymer-free bacteria were prepared and inoculated into subcutaneously implanted tissue cages. After three hours, the bacteria showed abundant capsular and intercellular exopolymers, which were visualized by transmission electron microscopy. Exopolymers were also produced by S. aureus exposed in electron microscopy. Exopolymers were also produced by S. aureus exposed in vitro to fluid from the tissue cage. In contrast, human serum albumin prevented exopolymer production by S. aureus. The influence of exopolymers on the susceptibility of S. aureus to ingestion and phagocytic killing by neutrophils was tested in vitro and found to be negligible. Furthermore, adherence of S. aureus to fibronectin-coated surfaces was unaffected by the presence or absence of exopolymers. Thus, in our experimental model, exopolymers are produced early during the onset of infection, but they have little impact on adherence and phagocytosis.